Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial
Brunner, Andrew M, Blonquist, Traci M, DeAngelo, Daniel J, McMasters, Malgorzata, Fell, Geoffrey, Hermance, Nicole M, Winer, Eric S, Lindsley, R Coleman, Hobbs, Gabriela S, Amrein, Philip C, Hock, HanJournal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(19)30203-0
Date:
December, 2019
Fichier:
PDF, 570 KB
2019
File converter
Plus de résultats de recherche
More benefits 
